Medicare Enrolled
Dr. Seth Rosen, MD
Hematology & Oncology · Port St Lucie, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rosen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rosen? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rosen
Dr. Seth Rosen is a hematology & oncology in Port St Lucie, FL, with 19 years in practice. Based on federal Medicare data, Dr. Rosen performed 212,578 Medicare services across 7,667 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rosen received a total of $13,167 from 77 pharmaceutical and/or device companies across 749 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rosen is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 2% volume in FL$ $13,167 industry payments
Medicare Practice Summary
Medicare Utilization ↗212,578
Medicare services
Top 2% in FL for hematology & oncology
7,667
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~11,188 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | 62,460 | $0 | $2 |
| Iron infusion (Feraheme) | 55,080 | $0 | $3 |
| Filgrastim injection (Nivestym) for white blood cells | 24,120 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 13,000 | $43 | $91 |
| Contrast dye for imaging (iodine-based) | 12,750 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 10,560 | $18 | $30 |
| Dexamethasone injection (steroid) | 3,576 | $0 | $1 |
| Epoetin alfa injection (Retacrit) for anemia | 3,400 | $6 | $24 |
| Complete blood count (CBC) with differential | 3,131 | $8 | $30 |
| Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 3,060 | $23 | $93 |
| Blood draw (venipuncture) | 2,371 | $8 | $15 |
| Comprehensive metabolic blood panel | 2,163 | $10 | $30 |
| Epoetin alfa injection (Procrit) for anemia | 1,810 | $6 | $20 |
| Office visit, established patient (20-29 min) | 1,429 | $69 | $210 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,190 | $1 | $10 |
| Drug injection, under skin or into muscle | 970 | $11 | $40 |
| Injection, fluorouracil, 500 mg | 849 | $2 | $10 |
| Office visit, established patient (30-39 min) | 683 | $100 | $300 |
| Ferritin level test (iron stores) | 681 | $13 | $40 |
| Iron level test | 677 | $6 | $20 |
| Iron binding capacity test | 677 | $9 | $25 |
| Anti-nausea injection (ondansetron/Zofran) | 500 | $0 | $2 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 499 | $1 | $6 |
| Administration of chemotherapy into vein, 1 hour or less | 493 | $106 | $330 |
| Injection of additional new drug or substance into vein | 445 | $13 | $55 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 434 | $24 | $85 |
| Lactate dehydrogenase (enzyme) level | 390 | $6 | $20 |
| Hospital follow-up visit, moderate complexity | 342 | $66 | $165 |
| Carcinoembryonic antigen (cea) protein level | 327 | $19 | $55 |
| Vitamin B-12 level test | 306 | $15 | $50 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 265 | $51 | $150 |
| Injection, diphenhydramine hcl, up to 50 mg | 262 | $1 | $4 |
| Folic acid level test | 241 | $14 | $55 |
| Infusion into a vein for hydration, each additional hour | 198 | $10 | $40 |
| Administration of chemotherapy into vein, each additional hour | 180 | $23 | $80 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 179 | $58 | $125 |
| Infusion, normal saline solution , 1000 cc | 175 | $2 | $10 |
| Magnesium level test | 169 | $7 | $20 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 144 | $137 | $441 |
| Infusion into a vein for hydration, 31-60 minutes | 138 | $26 | $125 |
| Prothrombin time test (blood clotting) | 127 | $4 | $15 |
| Injection, magnesium sulfate, per 500 mg | 120 | $1 | $2 |
| Anticoagulant management of patient taking warfarin | 117 | $8 | $25 |
| Irrigation of implanted venous access drug delivery device | 116 | $18 | $55 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 114 | $16 | $50 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 112 | $3 | $10 |
| Initial hospital admission, high complexity | 107 | $145 | $460 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 104 | $20 | $60 |
| Administration of additional new drug or substance into vein, 1 hour or less | 103 | $53 | $165 |
| PSA test (prostate cancer screening) | 100 | $18 | $75 |
| Ct scan of chest with contrast | 90 | $56 | $700 |
| New patient office visit, complex (60-74 min) | 83 | $168 | $520 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 82 | $408 | $681 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 81 | $1,195 | $5,700 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 78 | $27 | $85 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 75 | $4 | $12 |
| Ct scan of abdomen and pelvis before and after contrast | 74 | $204 | $1,450 |
| Uric acid level test | 63 | $4 | $10 |
| Blood creatinine level | 62 | $5 | $15 |
| Urea nitrogen level to assess kidney function, quantitative | 62 | $4 | $7 |
| Manual urinalysis test with examination using microscope, non-automated | 60 | $4 | $20 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 59 | $1 | $4 |
| Basic metabolic blood panel | 46 | $6 | $25 |
| Drawing of blood for a medical problem | 43 | $78 | $165 |
| Stool analysis for blood, by peroxidase activity | 40 | $4 | $10 |
| Collection of blood sample from implanted device | 38 | $21 | $50 |
| CT scan of chest, without contrast | 35 | $45 | $349 |
| Ct scan of abdomen and pelvis without contrast | 20 | $79 | $1,075 |
| New patient office visit (45-59 min) | 16 | $124 | $390 |
| Ct scan of soft tissue of neck with contrast | 14 | $59 | $550 |
| Office visit, established patient (10-19 min) | 13 | $43 | $130 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
26.6% high complexity
66.3% medium
7.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,167
Total received (2018-2024)
Avg $1,881/year across 7 years
Top 33% in FL for hematology & oncology
77
Companies
749
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,857 (97.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$310 (2.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$898
2023$1,262
2022$886
2021$1,109
2020$2,042
2019$3,435
2018$3,534
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$1,160
Janssen Biotech, Inc.
$862
Genentech USA, Inc.
$856
Takeda Pharmaceuticals U.S.A., Inc.
$764
PFIZER INC.
$761
AstraZeneca Pharmaceuticals LP
$716
E.R. Squibb & Sons, L.L.C.
$588
Novartis Pharmaceuticals Corporation
$579
Merck Sharp & Dohme Corporation
$400
GENZYME CORPORATION
$365
Lilly USA, LLC
$334
Incyte Corporation
$321
Celgene Corporation
$300
Seagen Inc.
$296
Bayer HealthCare Pharmaceuticals Inc.
$259
Astellas Pharma US Inc
$245
GlaxoSmithKline, LLC.
$219
Eisai Inc.
$205
Ipsen Biopharmaceuticals, Inc
$197
AbbVie Inc.
$187
EISAI INC.
$186
Seattle Genetics, Inc.
$178
Array BioPharma Inc.
$147
Gilead Sciences, Inc.
$146
AbbVie, Inc.
$132
Janssen Scientific Affairs, LLC
$122
ASD Specialty Healthcare, LLC
$119
Boston Scientific Corporation
$114
Exelixis Inc.
$112
Daiichi Sankyo Inc.
$108
AMAG Pharmaceuticals, Inc.
$106
Kite Pharma, Inc.
$103
Merck Sharp & Dohme LLC
$103
Boehringer Ingelheim Pharmaceuticals, Inc.
$100
Janssen Products, LP
$100
TESARO, Inc.
$97
Dova Pharmaceuticals
$88
ABBVIE INC.
$79
JAZZ PHARMACEUTICALS INC.
$77
Alexion Pharmaceuticals, Inc.
$74
Pharmacyclics LLC, An AbbVie Company
$70
Regeneron Healthcare Solutions, Inc.
$70
Mirati Therapeutics, Inc.
$63
TOLMAR Pharmaceuticals, Inc.
$63
Taiho Oncology, Inc.
$63
SOBI, INC
$62
Aveo Pharmaceuticals, Inc.
$54
Dendreon Pharmaceuticals LLC
$53
Janssen Pharmaceuticals, Inc
$53
Foundation Medicine, Inc.
$52
Karyopharm Therapeutics Inc.
$49
EMD Serono, Inc.
$42
BeiGene USA, Inc.
$40
PUMA BIOTECHNOLOGY, INC.
$39
Tolmar, Inc.
$38
Verastem, Inc.
$38
Grifols USA, LLC
$31
AVEO Pharmaceuticals, Inc.
$30
Helsinn Therapeutics (U.S.), Inc.
$28
Rigel Pharmaceuticals, Inc.
$27
Blueprint Medicines Corporation
$25
ARRAY BIOPHARMA INC
$23
TAIHO ONCOLOGY, INC.
$22
Pharmacyclics LLC, an AbbVie Company
$21
Cumberland Pharmaceuticals, Inc.
$20
COVIDIEN LP
$20
Myovant Sciences Inc.
$19
Coherus Biosciences Inc.
$18
MEDIVATION FIELD SOLUTIONS LLC
$18
ACCORD HEALTHCARE, INC.
$16
Puma Biotechnology, Inc.
$16
Kyowa Kirin, Inc.
$14
Aurobindo Pharma USA, Inc.
$14
Advanced Accelerator Applications
$13
Allergan Inc.
$13
Jazz Pharmaceuticals Inc.
$12
MorphoSys, US Inc.
$12
Top 3 companies account for 21.9% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BLENREP · BOSULIF · BRUKINSA · Bavencio · Braftovi · CABOMETYX · CALQUENCE · CAMCEVI · CHANTIX · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · EMPLICITI · ENJAYMO · EPKINLY · ERLEADA · EXKIVITY · Enhertu · Erleada · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · Fusilev · GAVRETO · GAZYVA · GILOTRIF · Gamunex-C · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LINZESS · LONSURF · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lupron Depot · Lutathera · MEKINIST · MONJUVI · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · ORGOVYX · Onivyde · PADCEV · PEMAZYRE · PILLCAM · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Perjeta · Prolia · REBLOZYL · Revlimid · SANCUSO · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SOMATULINE DEPOT · SPRYCEL · STELARA · SUTENT · Somatuline Depot · SpaceOAR VUE System - 10mL · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TUKYSA · Tavalisse · Tazverik · Tecentriq · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · Vectibix · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xofigo · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $6 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
24
Per 100K population
6.9
County median income
$69,027
Nearest hospital
ST LUCIE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Rosen is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Rosen experienced with injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram?
Based on Medicare claims data, Dr. Rosen performed 62,460 injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rosen receive payments from pharmaceutical companies?
Yes. Dr. Rosen received a total of $13,167 from 77 companies across 749 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rosen's costs compare to other hematology & oncologys in Port St Lucie?
Dr. Rosen's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rosen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Port St Lucie
Browse hematology & oncologys in Port St Lucie ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in FL
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in FL
Which FL hematology & oncologys receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology